These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1357057)

  • 1. Hepatocyte response to continuous low dose-rate radiation in radioimmunotherapy assessed by micronucleus assay.
    Sakahara H; Ono K; Saga T; Akuta K; Endo K; Konishi J; Abe M
    Int J Radiat Biol; 1992 Oct; 62(4):443-8. PubMed ID: 1357057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of micronuclei in hepatocytes following X and fast-neutron irradiations--an analysis by a linear-quadratic model.
    Ono K; Nagata Y; Akuta K; Abe M; Ando K; Koike S
    Radiat Res; 1990 Sep; 123(3):345-7. PubMed ID: 2217731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of the antitumor effect of radiolabeled monoclonal antibodies.
    Knox SJ; Levy R; Miller RA; Uhland W; Schiele J; Ruehl W; Finston R; Day-Lollini P; Goris ML
    Cancer Res; 1990 Aug; 50(16):4935-40. PubMed ID: 2379158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
    Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous hepatic radiation by labelled antibody: possible calculation of dose equivalence.
    Spencer RP
    Int J Radiat Biol; 1993 Nov; 64(5):641. PubMed ID: 7902404
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas.
    Sharkey RM; Goldenberg DM; Vagg R; Pawlyk D; Wong GY; Siegel JA; Murthy S; Levine GM; Izon D; Gascon P
    Cancer; 1994 Feb; 73(3 Suppl):864-77. PubMed ID: 8306272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
    Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
    Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy.
    Piron B; Paillas S; Boudousq V; Pèlegrin A; Bascoul-Mollevi C; Chouin N; Navarro-Teulon I; Pouget JP
    Nucl Med Biol; 2014 May; 41 Suppl():e75-83. PubMed ID: 24613681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S; Trisler K; Wessels BW; Knox SJ
    Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can preirradiation enhance tumor uptake of radiolabeled pharmaceuticals? Experimental data in a mouse neuroblastoma xenograft system.
    Sautter-Bihl ML; Bihl H
    Recent Results Cancer Res; 1996; 141():123-35. PubMed ID: 8722423
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G; Booth BJ; Batra SK; Colcher D
    Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model based calculation for effective cancer radioimmunotherapy.
    Attard AR; Chappell MJ; Bradwell AR
    Br J Radiol; 1995 Jun; 68(810):636-45. PubMed ID: 7627487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
    Divgi CR; Bander NH; Scott AM; O'Donoghue JA; Sgouros G; Welt S; Finn RD; Morrissey F; Capitelli P; Williams JM; Deland D; Nakhre A; Oosterwijk E; Gulec S; Graham MC; Larson SM; Old LJ
    Clin Cancer Res; 1998 Nov; 4(11):2729-39. PubMed ID: 9829736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodies.
    Behr TM; Juweid ME; Sharkey RM; Dunn RM; Ying Z; Becker WS; Siegel JA; Goldenberg DM
    Nucl Med Commun; 1996 Sep; 17(9):767-80. PubMed ID: 8895904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model.
    Flynn AA; Green AJ; Boxer GM; Casey JL; Pedley RB; Begent RH
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):183-9. PubMed ID: 9989525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
    Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
    J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
    Casey JL; King DJ; Chaplin LC; Haines AM; Pedley RB; Mountain A; Yarranton GT; Begent RH
    Br J Cancer; 1996 Nov; 74(9):1397-405. PubMed ID: 8912535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.